The earnings conference call will show a slight loss with revenue less than this quarter last year. That's right, this is biotech. We already know that. The "news" is really just to restate the pipeline is moving forward and the drugs are closer to the finish line.
It's tough for profit based technology companies to keep improving and investors rotate into biotech more. We should make a nice run over the next quarter.